Giacomo Ruotolo

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 17, 2026
Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes.

|Jul 29, 2025
Decreases in circulating ANGPTL3/8 concentrations following retatrutide treatment parallel reductions in serum lipids.

Yi Wen, Deven Lemen, Yanzhu Lin

|Jul 10, 2025
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial.

Daniel Gaudet, Malgorzata Gonciarz, Xi Shen

|Sep 20, 2021
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis.

Jonathan M Wilson, Yanzhu Lin, M Jane Luo

|Jan 19, 2021
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes.

Jonathan M Wilson, Amir Nikooienejad, Deborah A Robins

Pageof 1

Frequent Collaborators

5 joint publications

Axel Haupt

3 joint publications

Tamer Coskun

3 joint publications

Melissa K Thomas

2 joint publications

Deborah A Robins